Literature DB >> 24625116

Urinary angiotensinogen, related factors and clinical implications in normotensive autosomal dominant polycystic kidney disease patients.

Ilhan Kurultak1, Sule Sengul, Senem Kocak, Siyar Erdogmus, Reyhan Calayoglu, Pinar Mescigil, Kenan Keven, Sehsuvar Erturk, Bulent Erbay, Neval Duman.   

Abstract

BACKGROUND: Although several lines of evidence suggest that renin angiotensin system (RAS) proteins are synthesized by cyst epithelium and dilated tubules, role of intrarenal RAS in the progression of otozomal dominant polycystic kidney disease (ADPKD) is not well known. We aimed to study the levels and clinical correlations of urinary angiotensinogen (UAGT) in normotensive ADPKD patients compared with age- and sex-matched healthy subjects.
METHODS: The study included 20 normotensive ADPKD patients (F/M: 11/9) and 20 age and sex matched healthy controls (F/M: 9/11). Diagnosis of ADPKD was made based on Ravine criteria. Twenty-four hours ambulatory blood pressure monitoring (ABPM) was performed. Serum concentrations of creatinine, Na, K, uric acid, and urinary concentrations of Na, K, uric acid, creatinine, protein and albumin were measured. UAGT were measured via commercially available ELISA kit.
RESULTS: ADPKD patients had higher urinary albumin:creatinine ratio (UAIb/UCrea) than healthy controls (p < 0.01). UAGT/UCrea levels significantly positively correlated with urinary protein: creatinine ratio (UPro/UCrea) (r = 0.785, p = 0.01), and UAIb/UCrea (r = 0.681, p = 0.01) in normotensive ADPKD patients.
CONCLUSION: This pilot study demonstrates that UAGT levels tend to be elevated and are correlated with proteinuria and albuminuria in normotensive ADPKD patients during relatively early stages of the disease.

Entities:  

Keywords:  Albuminuria; autosomal dominant polycystic kidney disease; kidney damage; proteinuria; urinary angiotensinogen

Mesh:

Substances:

Year:  2014        PMID: 24625116     DOI: 10.3109/0886022X.2014.890857

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

Review 1.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

2.  Effect of unilateral nephrectomy on urinary angiotensinogen levels in living kidney donors: 1 year follow-up study.

Authors:  Zeynep Kendi Celebi; Ahmet Peker; Sim Kutlay; Senem Kocak; Acar Tuzuner; Sehsuvar Erturk; Kenan Keven; Sule Sengul
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Oct-Dec       Impact factor: 1.636

Review 3.  Independent regulation of renin-angiotensin-aldosterone system in the kidney.

Authors:  Akira Nishiyama; Hiroyuki Kobori
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

4.  Angiotensinogen and interleukin 18 in serum and urine of children with kidney cysts.

Authors:  Krzysztof Plesiński; Piotr Adamczyk; Elżbieta Świętochowska; Aurelia Morawiec-Knysak; Aleksandra Gliwińska; Omar Bjanid; Maria Szczepańska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2019 Jul-Sep       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.